Immunic, Inc. (IMUX)

Immunic Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	14.3	35.67	46.67	106.75	86.86	127.45
Short-Term Investments	-	-	-	9.63	-	-
Cash & Short-Term Investments	14.3	35.67	46.67	116.37	86.86	127.45
Cash Growth	-85.30%	-23.58%	-59.89%	33.97%	-31.85%	333.97%
Other Receivables	1.71	0.68	2.48	2.66	2.15	1.64
Receivables	1.71	0.68	2.48	2.66	2.15	1.64
Prepaid Expenses	1.7	1.87	2.31	5.61	15.98	4.65
Other Current Assets	1.25	1.11	1.07	1.23	-	-
Total Current Assets	18.98	39.33	52.53	125.86	104.99	133.75
Property, Plant & Equipment	1.54	1.54	1.77	1.85	1.1	1.1
Goodwill	-	-	-	-	32.97	32.97
Other Long-Term Assets	-	-	-	0.04	0.04	0.04
Total Assets	20.52	40.87	54.3	127.75	139.1	167.86
Accounts Payable	6.01	7.85	5.1	4.28	3.75	3.7
Accrued Expenses	18.29	12.91	18.66	7.99	7.07	4.32
Current Portion of Leases	0.77	0.74	0.7	0.57	0.41	0.3
Other Current Liabilities	0.53	0.68	0.27	0.24	0.18	0.08
Total Current Liabilities	25.59	22.18	24.73	13.08	11.4	8.4
Long-Term Leases	0.21	0.26	0.64	0.99	0.58	0.68
Total Liabilities	25.8	22.44	25.37	14.07	11.99	9.08
Common Stock	0.01	0.01	0	0	0	0
Additional Paid-In Capital	527.65	525.61	436.06	427.93	324.24	266.82
Retained Earnings	-536.87	-511.4	-410.89	-317.28	-196.87	-103.93
Comprehensive Income & Other	3.92	4.21	3.76	3.04	-0.25	-4.11
Total Common Equity	-5.29	18.43	28.93	113.68	127.12	158.79
Shareholders' Equity	-5.29	18.43	28.93	113.68	127.12	158.79
Total Liabilities & Equity	20.52	40.87	54.3	127.75	139.1	167.86
Total Debt	0.98	1	1.33	1.56	0.99	0.98
Net Cash (Debt)	13.33	34.66	45.34	114.81	85.87	126.48
Net Cash Growth	-86.14%	-23.55%	-60.51%	33.70%	-32.10%	338.41%
Net Cash Per Share	0.13	0.35	1.02	3.61	3.63	8.07
Filing Date Shares Outstanding	95.82	90.15	89.93	44.4	27.91	21.17
Total Common Shares Outstanding	90.15	90.15	45.18	39.31	26.34	21.17
Working Capital	-6.62	17.16	27.81	112.79	93.59	125.35
Book Value Per Share	-0.06	0.20	0.64	2.89	4.83	7.50
Tangible Book Value	-5.29	18.43	28.93	113.68	94.15	125.82
Tangible Book Value Per Share	-0.06	0.20	0.64	2.89	3.57	5.94

Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q